AI in Healthcare Strategic Roundup

Healthcare AI and Digital Health Strategic Roundup | July 3 – August 2, 2026

Healthcare AI and Digital Health Strategic Roundup exploring Developments and…


Gene and cell therapy strategy shaped by scalable manufacturing, broader treatment access, CAR-T expansion, and AI-enabled operations

Cell and Gene Therapy Strategic Roundup | June 24–July 29, 2026

Cell and Gene Therapy Strategic Roundup exploring Developments and Competitive…


Obesity Strategic Roundup

Obesity Strategic Roundup | June 22–July 27, 2026

Obesity Strategic Roundup exploring Developments and Competitive Shifts…


Cardiovascular Strategic Roundup

Cardiovascular Strategic Roundup | June 25–July 21, 2026

Cardiovascular Strategic Roundup exploring Developments and Competitive Shifts…


Endocrinology Strategic Roundup

Endocrinology Strategic Roundup | June 23–July 20, 2026

Strategic Developments and Competitive Shifts in Endocrinology Coverage Period:…


LucidScope_AI_Visibility_Analysis

AI perception of JAK Inhibitors in Atopic Dermatitis | LucidScope AI Visibility Audit

Key Findings from the LucidScope AI Visibility Analysis Rinvoq dominates AI…


Public Health Strategic Roundup

Public Health Strategic Roundup | June 11–July 15, 2026

Key Strategic Developments Shaping Public Health Coverage: June 11–July 15,…


Cell_Gene_Therapy

Cell and Gene Therapy 2025 Review: Acceleration, Accountability, and the Fight for Scalability

In 2025, Cell and Gene Therapy moved decisively from proof-of-concept to…


Gene_Therapy_AI

Gene Therapy: Efficacy, Safety, and Market Sentiment in an AI-Driven Search World

As AI increasingly mediates how patients, clinicians, and investors discover…


Privacy Preference Center